Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Nijole Kazlauskaite"'
Autor:
Rimantas Eidukevicius, Dainius Characiejus, Ramunas Janavicius, Nijole Kazlauskaite, Vita Pasukoniene, Mykolas Mauricas, Willem Den Otter
Publikováno v:
BMC Cancer, Vol 6, Iss 1, p 184 (2006)
BMC Cancer
BMC Cancer
Autor:
Nijole Kazlauskaite, Vita Pasukoniene, Rimantas Eidukevičius, Willem Den Otter, Dainius Characiejus, Mykolas Mauricas, Ramunas Janavicius
Publikováno v:
BMC cancer [Elektroninis išteklius], 2005, vol. 5, art. no 122, p. [1-11]
BMC Cancer
BMC Cancer, Vol 5, Iss 1, p 122 (2005)
BMC Cancer
BMC Cancer, Vol 5, Iss 1, p 122 (2005)
Background Presently available flow cytometric methods of bromodeoxyuridine (BrdUrd) labelling do not provide information on the cell cycle time (TC) and the growth fraction (GF). In this paper, we describe a novel and simple method to estimate TC an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c95d68d94e76a88343b7f3f61c47292
https://repository.vu.lt/VU:ELABAPDB6208838&prefLang=en_US
https://repository.vu.lt/VU:ELABAPDB6208838&prefLang=en_US
Autor:
Dainius, Characiejus, Vita, Pasukoniene, Nijole, Kazlauskaite, Konstantinas P, Valuckas, Tadas, Petraitis, Mykolas, Mauricas, Willem, Den Otter
Publikováno v:
Anticancer research. 22(6B)
The aim of this retrospective study was to evaluate the significance of pre-treatment levels of peripheral blood lymphocyte subsets for survival of renal cell carcinoma (RCC) patients treated with interferon-a2b (IFN).CD3+, CD19+, CD1656+, CD4+, CD8+
Autor:
J. Didziapetriene, G. Grazeliene, Nijole Kazlauskaite, D. Sukeliene, Giedre Streckyte, G Prasmickiene, Dainius Characiejus, L. Griciute, Ricardas Rotomskis
Publikováno v:
Cancer letters. 146(1)
The combination of photodynamic therapy (PDT) and Adriamycin (ADM) was studied in the animal model system. Photohem (PH) was used as a photosensitizer. Mice bearing carcinoma epidermoides LL of the lung received PH once at a dose 10 mg/kg and after 2
Publikováno v:
European Journal of Cancer. 33:S14
Autor:
Marius Strioga, Vita Pašukonienė, Neringa Dobrovolskienė, Tadas Petraitis, Nijolė Kazlauskaitė, Adas Darinskas, Lina Jokubauskienė, Dainius Characiejus
Publikováno v:
Acta Medica Lituanica, Vol 20, Iss 4 (2014)
Background. Antitumor immunotherapy strategies, such as cytokine- based or cell-based immunotherapies, are designed to activate immune response against cancer cells, but considering that malignancy may be associated with the expansion of immunosuppre
Externí odkaz:
https://doaj.org/article/51273305b0de42cdb99878b9965f74e8